Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • China Medical Technologies Inc. (CMED) Partners with Leica Biosystems to Co-develop, Market FISH Kits  0 comments
    Aug 8, 2011 5:34 PM | about stocks: CMEDQ
    China Medical Technologies, a leading China-based advanced in-vitro diagnostic (IVD) company, today announced its partnership with Leica Biosystems, a division of Leica Microsystems, a world leader in microscopes and scientific instruments.
     
    Collaboratively, the companies will co-develop and market automated FISH kits to be used on the Leica BOND system, an automated advanced staining platform. CMED will market the automated FISH kits in China, while Leica has the option to sell the automated FISH kits in the rest of the world.
     
    The FISH solutions are designed for tissue sample tests on HER-2, EGFR and TOP2A, genes in connection with the targeted cancer therapy drugs for breast cancer, lung cancer and stomach cancer patients. By creating an automated system of these FISH tests on the Leica BOND system, pathology laboratories and independent service laboratories can run these diagnostic tests more efficiently and with higher and more consistent quality.
     
    The partnership reflects a key achievement for CMED, extending its global reach.
     
    “These collaborations with Leica mark a significant milestone for us,” Xiaodong Wu, chairman and CEO of CMED stated in the press release. “We believe that FISH applications will be more widely used in various clinical applications on automated basis in the future. By partnering with Leica, one of the leading global players in anatomic pathology, we can provide more efficient and higher quality FISH diagnostic solutions to the end users not only in China, but also in the global markets through Leica’s extensive global network.”
     
    The deal is expected to not only benefit both companies, but their customers as well.
     
    “CMED is the market leader for FISH based diagnostics in China and has played a key role in the rapid development in the use of FISH in China, especially for tissue based companion diagnostic testing. This partnership will help Leica and CMED to offer customers in China a broad test menu of high quality FISH tests automated on the Leica BOND system,” commented Arnd Kaldowski, president of Leica Biosystems.
     
    For more information visit chinameditech.com or leica-microsystems.com
     
    Please see disclaimer on the MissionIR website www.missionir.com/disclaimer.html ;
     
    Stocks: CMEDQ
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.